Skip to main content
Log in

Die Defibrillatorweste

Passagerer Schutz vor dem plötzlichen Herztod

The wearable cardioverter/defibrillator

Temporary protection from sudden cardiac death

  • Schwerpunkt: Interventionelle Therapien II
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Der plötzliche Herztod ist in der überwiegenden Zahl der Fälle bedingt durch ventrikuläre Tachyarrhythmien. Implantierbare Kardioverter/Defibrillatoren (ICD) stellen heute eine evidenzbasierte und gut etablierte Methode zur Prävention des plötzlichen Herztods dar. Für Patienten, die die Kriterien für eine leitliniengerechte ICD-Implantation nicht erfüllen und dennoch ein erhöhtes, z. B. transientes, Risiko für den plötzlichen Herztod haben, wurde der tragbare Kardioverter/Defibrillator („wearable cardioverter/defibrillator“ [WCD]) etabliert. Zahlreiche Studien konnten die Sicherheit und Effektivität des WCD belegen, auch wenn randomisierte Studien zum Nachweis einer Reduktion der Mortalität und Prognoseverbesserung noch fehlen. Diese Übersichtsarbeit liefert einen Überblick über die aktuelle Datenlage, die Indikationen für den WCD sowie dessen potenzielle Risiken und Komplikationen.

Abstract

In the majority of cases sudden cardiac death (SCD) is caused by ventricular tachyarrhythmia. Implantable cardioverter-defibrillators (ICD) represent an evidence-based and established method for prevention of SCD. For patients who do not fulfill the criteria for guideline-conform implantation of an ICD but still have an increased, e.g. transient risk for SCD, a wearable cardioverter-defibrillator (WCD) vest was developed to temporarily prevent SCD. Numerous studies have shown the safety and efficacy of the WCD, although there is still a gap in evidence concerning a reduction in overall mortality and improvement in prognosis. This article gives an overview on the currently available literature on WCD, the indications, potential risks and complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Auricchio A, Klein H, Geller CJ et al (1998) Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation. Am J Cardiol 81:1253–1256

    Article  CAS  PubMed  Google Scholar 

  2. Bauersachs J, Arrigo M, Hilfiker-Kleiner D et al (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. doi:10.1002/ejhf.586

    PubMed  Google Scholar 

  3. Chung MK, Szymkiewicz SJ, Shao M et al (2010) Aggregate national experience with the wearable cardioverter-defibrillator: Event rates, compliance, and survival. J Am Coll Cardiol 56:194–203. doi:10.1016/j.jacc.2010.04.016

    Article  PubMed  PubMed Central  Google Scholar 

  4. Dillon KA, Szymkiewicz SJ, Kaib TE (2010) Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm. J Electrocardiol 43:63–67. doi:10.1016/j.jelectrocard.2009.05.010

    Article  PubMed  Google Scholar 

  5. Duncker D, Haghikia A, König T et al (2014) Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail 16:1331–1336. doi:10.1002/ejhf.188

    Article  PubMed  Google Scholar 

  6. Duncker D, König T, Hohmann S, Veltmann C (2015) Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies. Herzschrittmacherther Elektrophysiol 26:82–93. doi:10.1007/s00399-015-0372-8

    Article  CAS  PubMed  Google Scholar 

  7. Duncker D, Veltman C (2016) The wearable cardioverter/defibrillator – toy or tool? J Atr Fibrillation 8:69–77

    Google Scholar 

  8. Epstein AE, Abraham WT, Bianco NR et al (2013) Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol 62:2000–2007. doi:10.1016/j.jacc.2013.05.086

    Article  PubMed  Google Scholar 

  9. Feldman AM, Klein H, Tchou P et al (2004) Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: Results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 27:4–9

    Article  PubMed  Google Scholar 

  10. Goldenberg I, Vyas AK, Hall WJ et al (2008) Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51:288–296. doi:10.1016/j.jacc.2007.08.058

    Article  PubMed  Google Scholar 

  11. Healy CA, Carrillo RG (2015) Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation. Heart Rhythm 12:1565–1573. doi:10.1016/j.hrthm.2015.03.061

    Article  PubMed  Google Scholar 

  12. Kutyifa V, Moss AJ, Klein H et al (2015) Use of the wearable cardioverter defibrillator in high-risk cardiac patients: Data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry). Circulation 132(17):1613–1619. doi:10.1161/CIRCULATIONAHA.115.015677

    Article  PubMed  Google Scholar 

  13. Martens E, Sinner MF, Siebermair J et al (2014) Incidence of sudden cardiac death in Germany: results from an emergency medical service registry in Lower Saxony. Europace 16:1752–1758. doi:10.1093/europace/euu153

    Article  PubMed  PubMed Central  Google Scholar 

  14. Neuzner J, Gradaus R (2015) ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection. Herzschrittmacherther Elektrophysiol 26:75–81. doi:10.1007/s00399-015-0371-9

    Article  CAS  PubMed  Google Scholar 

  15. Piccini JP, Allen LA, Kudenchuk PJ et al (2016) Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: A science advisory from the American Heart Association. Circulation 133:1715–1727. doi:10.1161/CIR.0000000000000394

    Article  PubMed  Google Scholar 

  16. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J:ehw128–ehw85. doi:10.1093/eurheartj/ehw128

  17. Priori SG, Blomström-Lundqvist C, Mazzanti A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36:2793–2867. doi:10.1093/eurheartj/ehv316

    Article  PubMed  Google Scholar 

  18. Prochnau D, Surber R, Kuehnert H et al (2010) Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction. Clin Res Cardiol 99:129–131. doi:10.1007/s00392-009-0093-2

    Article  PubMed  Google Scholar 

  19. Rao M, Goldenberg I, Moss AJ et al (2011) Wearable defibrillator in congenital structural heart disease and inherited arrhythmias. Am J Cardiol 108:1632–1638. doi:10.1016/j.amjcard.2011.07.021

    Article  PubMed  Google Scholar 

  20. Reek S, Geller JC, Meltendorf U et al (2003) Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol 26:2016–2022

    Article  PubMed  Google Scholar 

  21. Saltzberg MT, Szymkiewicz S, Bianco NR (2012) Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 18:21–27. doi:10.1016/j.cardfail.2011.09.004

    Article  PubMed  Google Scholar 

  22. Schwab JO, Bänsch D, Israel C, Nowak B (2015) Statement on the use of wearable cardioverter defibrillators. Kardiologe 9:165–170. doi:10.1007/s12181-015-0651-y

    Article  Google Scholar 

  23. Sheppard R, Mather PJ, Alexis JD et al (2012) Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2. J Card Fail 18:675–681. doi:10.1016/j.cardfail.2012.07.004

    Article  PubMed  Google Scholar 

  24. Sjöblom J, Muhrbeck J, Witt N et al (2014) Evolution of left ventricular ejection fraction after acute myocardial infarction: Implications for implantable cardioverter-defibrillator eligibility. Circulation 130:743–748. doi:10.1161/CIRCULATIONAHA.114.009924

    Article  PubMed  Google Scholar 

  25. Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767–778. doi:10.1093/eurjhf/hfq120

    Article  PubMed  Google Scholar 

  26. Tanawuttiwat T, Garisto JD, Salow A et al (2014) Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator. Pacing Clin Electrophysiol 37:562–568. doi:10.1111/pace.12319

    Article  PubMed  Google Scholar 

  27. van der Heijden AC, Borleffs CJW, Buiten MS et al (2015) The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm 12:1169–1176. doi:10.1016/j.hrthm.2015.02.035

    Article  PubMed  Google Scholar 

  28. Wan C, Herzog CA, Zareba W, Szymkiewicz SJ (2014) Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator. Ann Noninvasive Electrocardiol 19:247–257. doi:10.1111/anec.12119

    Article  PubMed  Google Scholar 

  29. Zishiri ET, Williams S, Cronin EM et al (2013) Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythmia Electrophysiol 6:117–128. doi:10.1161/CIRCEP.112.973552

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Duncker.

Ethics declarations

Interessenkonflikt

D. Duncker erhielt Vortragshonorare und Reisekostenunterstützung von ZOLL, C. Veltmann erhielt Vortragshonorare, Reisekostenunterstützung und Forschungsmittel von ZOLL. J. Bauersachs gibt an, dass kein Interessenkonflikt besteht.

Bei diesem Beitrag handelt es sich um eine Übersichtsarbeit. Es werden keine bislang unpublizierten Studiendaten präsentiert.

Additional information

Redaktion

H. Haller, Hannover

G. Hasenfuß, Göttingen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duncker, D., Bauersachs, J. & Veltmann, C. Die Defibrillatorweste. Internist 57, 864–870 (2016). https://doi.org/10.1007/s00108-016-0110-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-016-0110-2

Schlüsselwörter

Keywords

Navigation